Synthesis of some C-3,4,5-substituted 2,6-dimethyl-1,4-dihydropyridines (4-DHPs)

Synthetic Communications

Volumn 37, Issue 12, 2007, Pages 2051-2060

  Navarrete Encina, Patricio A ^a   Squella, Juan A ^a   Carbajo, J ^b   Conde, B ^b   Núñez Vergara, Luis J ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b Faculty of Experimental Sciences   (Spain)

Author keywords

1,4 dihydropyridines; Cyclization; Nitrogen heterocycles

Indexed keywords

DIHYDROPYRIDINE DERIVATIVE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS; SUBSTITUTION REACTION; TEMPERATURE MEASUREMENT;

EID: 34250363041     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397910701357007     Document Type: Article

References (24)

1. Godfrain, T. Cardioselectivity of calcium antagonists. Cardiovas. Drugs Therap. 1994, 8, 353-364.
2. (a) Mak, I. T.; Kramer, J. H.; Weglicki, W. B. Antioxidant properties of active and inactive isomers of nicardipine in cardiac membranes, endothelial-cells, and perfused rat hearts. Cor. Artery Disc. 1992, 3 (11), 1095-1103;
3. (b) Mason, R. P.; Mak, I. T.; Trumbore, M. W.; Mason, P. E. Antioxidant properties of calcium antagonists related to membrane biophysical interactions. Am. J. Cardiol. 1999, 84, 16L-22L.
4. (a) Ortiz, M. E.; Nuñez-Vergara, L. J.; Camargo, C.; Squella, J. A. Oxidation of Hantzsch 1,4-dihydropyridines of pharmacological significance by electrogenerated superoxide. Pharm. Res. 2004, 21 (3), 428-435;
5. (b) Yañez, C.; López-Alarcón, C.; Camargo, C.; Valenzuela, V.; Squella, J. A.; Nuñez-Vergara, L. J. Structural effects on the reactivity 1,4-dihydropyridines with alkylperoxyl radicals and ABTS radical cation. Bioorg. Med. Chem. 2004, 12 (9), 2459-2468;
6. (c) Nunez-Vergara, L. J.; López-Alarcón, C.; Navarrete-Encina, P. A.; Atria, A. M.; Camargo, C.; Squella, J. A. Electrochemical and EPR characterization of 1,4-dihydropyridines: Reactivity towards alkyl radicals. Free Rad. Res. 2003, 37 (1), 109-120.
7. (a) Stout, D. M.; Meyers, A. I. Recent advances in the chemistry of dihydropyridines. Chem. Rev. 1982, 82, 223-243;
8. (b) Eisner, U.; Kuthan, J. The chemistry of dihydropyridines. Chem. Rev. 1972, 72 (1), 1-42.
9. (a) Ilavsky, D.; Milata, V. Syntheses and spectral properties of unsymmetrically 3,5-disubstituted 2,6-dimethyl-1,4-dihydropyridines. Collect. Czech. Chem. Comm. 1996, 61, 1233-1243;
10. (b) Zenouz, A. M.; Oskuie, M. R.; Mollazadeh, S. Synthesis of novel asymmetrical 1,4-dihydropyridine derivatives. Synth. Commun. 2005, 35 (22), 2895-2903;
11. (c) Zenouz, A. M.; Allahverdi, S. S.; Raissossadat, M.; Sadeghi, Q. Synthesis of the C-2 functionalized 1,4-dihydropyridines. Asian J. Chem. 2005, 17 (4), 2639-2643.
12. López-Alarcón, C.; Navarrete, P.; Camargo, C.; Squella, J. A. Nuñez-Vergara, L. J. Reactivity of 1,4-dihydropyridines toward alkyl, alkylperoxyl radicals, and ABTS radical cation. Chem. Res. Toxicol. 2003, 16 (2), 208-215.
13. (a) Velasquez, C.; Vo, D.; Knaus, E. E. Syntheses, calcium channel modulation effects, and nitric oxide release studies of O-2-alkyl-1-(pyrrolidin- 1-yl)-diazen-1-ium-1,2-diolate-4-aryl(heteroaryl)-1,4-dihydro-2, 6-dimethyl-3-nitropyridine-5-carboxylates. Drug. Dev. Res. 2003, 60 (3), 204-216;
14. (b) Di Stilo, A.; Visentin, S.; Cena, C.; Gasco, A. M.; Ermondi, G.; Gasco, A. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities. J. Med. Chem. 1998, 41 (27), 5393-5401.
15. (a) Satoh, Y.; Ichihashi, M.; Okumura, K. Studies on nivaldipine.1: Synthesis and structure-activity relationships of 1,4-dihydropyridines containing novel substituents at the 2-position. Chem. Pharm. Bull. 1991, 39, 3189;
16. (b) Kanno, H.; Yamaguchi, H.; Okamiya, Y.; Sunakawa, K.; Takeshita, T.; Naruchi, T. Synthesis and antihypertensive activity of 1,4-dihydropyridine derivatives with a 4-(disubstituted phenyl) ring and an aminoalkyl ester group: Highly potent and long-lasting calcium antagonists. Chem. Pharm. Bull. 1992, 40 (8), 2049.
17. Mannhold, R. Calcium antagonists: Basic chemical and pharmacological properties. Drugs of Today 1984, 20 (2), 69-90.
18. (a) Núñez-Vergara, L. J.; Squella, J. A.; Bollo-Dragnic, S.; Morello, A.; Repetto, Y.; Aldunate, J.; Letelier, M. Nitro aryl 1,4-dihydropyridine derivatives: Effects on Trypanosoma cruzi. Comp. Biochem. Physiol. 1997, 118 (1), 105-111;
19. (b) Núñez-Vergara, L. J.; Squella, J. A.; Bollo-Dragnic, S.; Marín-Catalán, R.; Pino, L.; Díaz, G.; Letelier, M. E. Gen. Pharmacol. 1998, 30 (1), 85;
20. (c) Maya, J. D.; Morello, A.; Repetto, Y.; Tellez, R.; Rodriguez, A.; Zelada, O.; Puebla, P.; Caballero, E.; Medarte, M.; Núñez-Vergara, L. J.; Squella, J. A.; Bontá, M.; Bollo, S.; San Feliciano, A. Effects of 3-chloro-phenyl-1,4-dihydropyridine derivatives on Trypanosome cruzi epimastigotes. Comp. Biochem. Physiol. 2000, 125C, 103-109;
21. (d) Maya, J. D.; Morello, A.; Repetto, Y.; Rodríguez, A.; Puebla, P.; Caballero, E.; Medarde, M.; Núñez-Vergara, L. J.; Squella, J. A.; Ortiz, M. E.; Fuentealba, J.; San Feliciano, A. Trypanosoma cruzi: Inhibition of parasite growth and respiration by oxazolo(thiazolo)pyridine derivatives and its relationship to redox potential and lipophilicity. Exp. Parasitol. 2001, 99, 1-6.
22. Zhang, Y. H.; Zhang, Z. Q.; Wu, Q. Synthesis of alkyl 2,6-dimethyl-(substituted or unsubstituted furyl)-1,4-dihydropyridine-3,5- dicarboxylates. Acta Pharmaceutica Sinica. 1991, 26 (5), 375-378.
23. Hafiz, I. S. A.; Darwish, E. S.; Mahmoud, F. F. Utility of 3-aminocrotononitrile in the synthesis of new methyl 1,4-dihydropyridine, methylquinoline and thiophene derivatives: Reactivity of the methyl function in alkyl 1,4-dihydropyridine and methyl quinoline derivatives towards some electrophilic reagents. J. Chem. Res. Synop. 1999, 9, 536.
24. 13C NMR spectroscopy. Tetrahedron. 1986, 42 (20), 5729-5738.